Actively Recruiting
Multi-site HPV Screening by High-throughput Sequencing in Patients With Chronic HPV-HR Infection Followed by Gynecology
Led by University Hospital, Toulouse · Updated on 2024-07-19
30
Participants Needed
1
Research Sites
179 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main risk of developing cervical cancer is the persistence of an High risk human papillomavirus (HPV-HR) infection, the mechanisms of which are still not understood. These chronically infected patients could develop multi-site lesions. The main objective is to assess the feasibility of setting up a personalized screening in patients at high risk of cervical cancer (chronically infected with HPV), by evaluating documenting the acceptability of these patients to be sampled from the ENT sphere and anal spheres for HPV analysis with next-generation sequencing.
CONDITIONS
Official Title
Multi-site HPV Screening by High-throughput Sequencing in Patients With Chronic HPV-HR Infection Followed by Gynecology
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Chronic high-risk HPV infection persisting at least 6 months after treatment of cervical or vaginal injury, or recurrence of high-grade cervical/vaginal lesion (CIN2, CIN3, HSIL) or cancer
- Written consent to participate in the study
- Affiliated with or beneficiary of a social security scheme
You will not qualify if you...
- Infection or persistent lesion linked only to low-risk HPV
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Toulouse
Toulouse, France
Actively Recruiting
Research Team
E
Elodie Chantalat, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here